{"id":"https://openalex.org/W4390949099","doi":"https://doi.org/10.1038/s41397-023-00321-y","title":"Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies","display_name":"Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies","publication_year":2024,"publication_date":"2024-01-17","ids":{"openalex":"https://openalex.org/W4390949099","doi":"https://doi.org/10.1038/s41397-023-00321-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/38233388"},"language":"en","primary_location":{"id":"doi:10.1038/s41397-023-00321-y","doi":"https://doi.org/10.1038/s41397-023-00321-y","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41397-023-00321-y","pdf_url":null,"source":{"id":"https://openalex.org/S141213272","display_name":"The Pharmacogenomics Journal","issn_l":"1470-269X","issn":["1470-269X","1473-1150"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pharmacogenomics Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093731044","display_name":"Mar\u00eda Est\u00e9vez-Paredes","orcid":"https://orcid.org/0000-0002-7096-7749","observed_orcids":["https://orcid.org/0000-0002-7096-7749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mar\u00eda Est\u00e9vez-Paredes","raw_affiliation_strings":["CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain"],"raw_orcid":"https://orcid.org/0000-0002-7096-7749","affiliations":[{"raw_affiliation_string":"CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","institution_ids":[]},{"raw_affiliation_string":"INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067466164","display_name":"Carmen Mata-Mart\u00edn","orcid":"https://orcid.org/0000-0002-1849-1093","observed_orcids":["https://orcid.org/0000-0002-1849-1093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Carmen Mata-Mart\u00edn","raw_affiliation_strings":["CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain"],"raw_orcid":"https://orcid.org/0000-0002-1849-1093","affiliations":[{"raw_affiliation_string":"CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","institution_ids":[]},{"raw_affiliation_string":"INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028468456","display_name":"Fernando de Andr\u00e9s","orcid":"https://orcid.org/0000-0003-1076-0743","observed_orcids":["https://orcid.org/0000-0003-1076-0743"]},"institutions":[{"id":"https://openalex.org/I79189158","display_name":"University of Castilla-La Mancha","ror":"https://ror.org/05r78ng12","country_code":"ES","type":"education","lineage":["https://openalex.org/I79189158"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Fernando de Andr\u00e9s","raw_affiliation_strings":["CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","Department of Analytical Chemistry and Food technology, Faculty of Pharmacy, University of Castilla-La Mancha, Albacete, Spain","INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain"],"raw_orcid":"https://orcid.org/0000-0003-1076-0743","affiliations":[{"raw_affiliation_string":"CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","institution_ids":[]},{"raw_affiliation_string":"Department of Analytical Chemistry and Food technology, Faculty of Pharmacy, University of Castilla-La Mancha, Albacete, Spain","institution_ids":["https://openalex.org/I79189158"]},{"raw_affiliation_string":"INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025811853","display_name":"Adri\u00e1n LLerena","orcid":"https://orcid.org/0000-0002-5663-7081","observed_orcids":["https://orcid.org/0000-0002-5663-7081","https://orcid.org/0000-0003-1076-0743"]},"institutions":[{"id":"https://openalex.org/I80606768","display_name":"Universidad de Extremadura","ror":"https://ror.org/0174shg90","country_code":"ES","type":"education","lineage":["https://openalex.org/I80606768"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Adri\u00e1n LLerena","raw_affiliation_strings":["CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain. allerena@unex.es","Faculty of Medicine, University of Extremadura, Badajoz, Spain. allerena@unex.es","INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain. allerena@unex.es","CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain"],"raw_orcid":"https://orcid.org/0000-0002-5663-7081","affiliations":[{"raw_affiliation_string":"CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain. allerena@unex.es","institution_ids":[]},{"raw_affiliation_string":"Faculty of Medicine, University of Extremadura, Badajoz, Spain. allerena@unex.es","institution_ids":["https://openalex.org/I80606768"]},{"raw_affiliation_string":"INUBE Extremadura Biosanitary Research Institute, Badajoz, Spain. allerena@unex.es","institution_ids":[]},{"raw_affiliation_string":"CICAB Clinical Research Centre, Pharmacogenetics and Personalized Medicine Unit, Badajoz University Hospital, Extremadura Health Service, Badajoz, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5025811853"],"corresponding_institution_ids":["https://openalex.org/I80606768"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":3.3149,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.92207395,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"24","issue":"1","first_page":"2","last_page":"2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pharmacogenetic-markers","display_name":"pharmacogenetic markers","score":0.9139999747276306},{"id":"https://openalex.org/keywords/drug-labels","display_name":"drug labels","score":0.8190000057220459},{"id":"https://openalex.org/keywords/regulatory-agencies","display_name":"regulatory agencies","score":0.4359999895095825},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.902999997138977}],"concepts":[{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.8883606195449829},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.8232845664024353},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7410176992416382},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6845155358314514},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5618112087249756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5189282894134521},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.49211376905441284},{"id":"https://openalex.org/C2994119904","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Drug response","level":3,"score":0.43471062183380127},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14647075533866882},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.11193099617958069},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09431815147399902},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07671478390693665},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071185","descriptor_name":"Pharmacogenomic Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004348","descriptor_name":"Drug Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/s41397-023-00321-y","doi":"https://doi.org/10.1038/s41397-023-00321-y","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41397-023-00321-y","pdf_url":null,"source":{"id":"https://openalex.org/S141213272","display_name":"The Pharmacogenomics Journal","issn_l":"1470-269X","issn":["1470-269X","1473-1150"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pharmacogenomics Journal","raw_type":"journal-article"},{"id":"pmid:38233388","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38233388","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The pharmacogenomics journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2233000430","display_name":null,"funder_award_id":"PMP22/00099","funder_id":"https://openalex.org/F4320321837","funder_display_name":"Ministerio de Econom\u00eda y Competitividad"},{"id":"https://openalex.org/G4065834889","display_name":null,"funder_award_id":"IMP/000009","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G4922179846","display_name":"EVALUACI\u00d3N DE UNA PROPUESTA DE IMPLEMENTACI\u00d3N DE FARMACOGEN\u00c9TICA EN EL SISTEMA NACIONAL DE SALUD.","funder_award_id":"PMP22/00099","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G4983661167","display_name":null,"funder_award_id":"IMP/000009","funder_id":"https://openalex.org/F4320321837","funder_display_name":"Ministerio de Econom\u00eda y Competitividad"}],"funders":[{"id":"https://openalex.org/F4320321837","display_name":"Ministerio de Econom\u00eda y Competitividad","ror":"https://ror.org/034900433"},{"id":"https://openalex.org/F4320324675","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1558513201","https://openalex.org/W1896195310","https://openalex.org/W1972020659","https://openalex.org/W1977630488","https://openalex.org/W2024612136","https://openalex.org/W2047913288","https://openalex.org/W2058792255","https://openalex.org/W2063280109","https://openalex.org/W2064439826","https://openalex.org/W2085025074","https://openalex.org/W2120706437","https://openalex.org/W2138018801","https://openalex.org/W2158815828","https://openalex.org/W2163580654","https://openalex.org/W2166756090","https://openalex.org/W2277426755","https://openalex.org/W2285439387","https://openalex.org/W2403918916","https://openalex.org/W2422461554","https://openalex.org/W2470856629","https://openalex.org/W2784298528","https://openalex.org/W2801692980","https://openalex.org/W2802492879","https://openalex.org/W2889618178","https://openalex.org/W2914963468","https://openalex.org/W2919161650","https://openalex.org/W2990786623","https://openalex.org/W2995023761","https://openalex.org/W2999853148","https://openalex.org/W2999915091","https://openalex.org/W3004430629","https://openalex.org/W3013258041","https://openalex.org/W3020167142","https://openalex.org/W3092772878","https://openalex.org/W3125038886","https://openalex.org/W3137462095","https://openalex.org/W4210378359","https://openalex.org/W4214594003","https://openalex.org/W4237007883"],"related_works":["https://openalex.org/W2990786623","https://openalex.org/W2988386492","https://openalex.org/W4407230318","https://openalex.org/W4379882786","https://openalex.org/W619966722","https://openalex.org/W2470856629","https://openalex.org/W3181003542","https://openalex.org/W1982716292","https://openalex.org/W2504390295","https://openalex.org/W4414586749"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-01-18T00:00:00"}